Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by Joelzinhoon Nov 15, 2017 7:44pm
151 Views
Post# 26972462

RE:RE:RE:RE:RE:RE:RE:RE:Ceapro Reports 2017 Third Quarter Business Update

RE:RE:RE:RE:RE:RE:RE:RE:Ceapro Reports 2017 Third Quarter Business Update
oats wrote: Iscfa

I believe that you are factually incorrect.

Hopefully, digitel can confirm this but my understanding is that Cearpo produces the purest form of Beta Glucan available.  Based on this, they do have a competetive advantage.

If this is such an issue to you, call the company or the IR rep and ask the question.  Also, if you think that the company lying to you in the press release, this is another reason why you should call the company or the IR rep.  If you can't or won't do that for yourself, you are not a shareholder.  If you are a shareholder, you likely have created a reason for yourself to sell.  

Further, if you look at the news release today, you will see Beta Glucan mentioned numerous times, does it sound like they are moving out of this space to you?


Have you, or anyone been able to get in touch with IR or the IR rep?

I have been able to get in touch with Ceapro head office whenever I spoke. However, the IR rep. is another story. I have left message wtih them, sent emails, numerous times, and have yet to receive any similance of a response. Concerning to say the least.

Bullboard Posts